Cargando…

Attenuating effects of allantoin on oxidative stress in a mouse model of nonalcoholic steatohepatitis: role of SIRT1/Nrf2 pathway

BACKGROUND AND PURPOSE: Nonalcoholic steatohepatitis (NASH) is considered a common and serious liver disease, which develops into cirrhosis, fibrosis, and even hepatocellular carcinoma. Oxidative stress is identified as an important factor in the induction and promotion of NASH. Allantoin is a natur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamidi-zad, Zeinab, Moslehi, Azam, Rastegarpanah, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562413/ https://www.ncbi.nlm.nih.gov/pubmed/34760013 http://dx.doi.org/10.4103/1735-5362.327511

Ejemplares similares

Allantoin improves methionine-choline deficient diet-induced nonalcoholic steatohepatitis in mice through involvement in endoplasmic reticulum stress and hepatocytes apoptosis-related genes expressions
por: Komeili Movahhed, Tahereh, et al.
Publicado: (2019)

Role of SREBPs in Liver Diseases: A Mini-review
por: Moslehi, Azam, et al.
Publicado: (2018)

Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse
por: Zhou, Lishan, et al.
Publicado: (2017)

Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway
por: Qiu, Tianming, et al.
Publicado: (2018)

Antihypertensive Action of Allantoin in Animals
por: Chen, Mei-Fen, et al.
Publicado: (2014)

Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice
por: Li, Rui, et al.
Publicado: (2018)

Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis
por: Lee, Jung Il, et al.
Publicado: (2019)

Intestinal Dysbiosis, the Tryptophan Pathway and Nonalcoholic Steatohepatitis
por: Chen, Jiezhong, et al.
Publicado: (2022)

Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis
por: Akiyama, Kentaro, et al.
Publicado: (2017)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
por: Mazo, Daniel FC, et al.
Publicado: (2013)

A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis
por: Ai, Luoyan, et al.
Publicado: (2015)

Complement Alternative Pathway Activation in Human Nonalcoholic Steatohepatitis
por: Segers, Filip M., et al.
Publicado: (2014)

Establishment and Comparison of Juvenile Female Mouse Models of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Zhou, Lishan, et al.
Publicado: (2018)

Isoorientin Attenuates Cisplatin-Induced Nephrotoxicity Through the Inhibition of Oxidative Stress and Apoptosis via Activating the SIRT1/SIRT6/Nrf-2 Pathway
por: Fan, Xiaoye, et al.
Publicado: (2020)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Publicado: (2013)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
por: Lu, Yifei, et al.
Publicado: (2022)

Rho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis
por: Dohnalkova, Ester, et al.
Publicado: (2023)

Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity
por: Chen, Xu, et al.
Publicado: (2018)

Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
por: Kessoku, Takaomi, et al.
Publicado: (2016)

Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis
por: Ozawa, Yusuke, et al.
Publicado: (2018)

Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
por: Komiya, Chikara, et al.
Publicado: (2017)

Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis
por: Raselli, Tina, et al.
Publicado: (2019)

Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet
por: Ganguly, Souradipta, et al.
Publicado: (2021)

Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse model
por: Noichi, Jun, et al.
Publicado: (2022)

Diet-Induced Mouse Model of Nonalcoholic Steatohepatitis That Replicates the Human Disease
por: Caviglia, Jorge, et al.
Publicado: (2022)

Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis
por: Reisman, Scott A., et al.
Publicado: (2020)

Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Abdollahiyan, Sara, et al.
Publicado: (2023)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Genistein Attenuates Nonalcoholic Steatohepatitis and Increases Hepatic PPARγ in a Rat Model
por: Susutlertpanya, Warinda, et al.
Publicado: (2015)

Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice
por: Ono, Masafumi, et al.
Publicado: (2013)

Myeloid FoxO1 depletion attenuates hepatic inflammation and prevents nonalcoholic steatohepatitis
por: Lee, Sojin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qfhch1idqqlg09blkdg0vclv6